This article is a retraction of:
RETRACTED: COL10A1-DDR2 axis promotes the progression of pancreatic cancer by regulating MEK/ERK signal transduction
A Retraction of the Original Research Article
COL10A1-DDR2 axis promotes the progression of pancreatic cancer by regulating MEK/ERK signal transduction
by Wen Z, Sun J, Luo J, Fu Y, Qiu Y, Li Y, Xu Y, Wu H and Zhang Q (2022) Front. Oncol. 12:1049345. doi: 10.3389/fonc.2022.1049345
The journal retracts the 2022 article cited above.
Following publication, the authors contacted the Editorial Office to request the retraction of the cited article, stating that there were errors in the figures. The findings reported in the article are no longer supported by the data. An investigation was conducted in in accordance with Frontiers’ policies that confirmed this; therefore, the article has been retracted.
This retraction was approved by the Chief Editors of Frontiers in Oncology and the Chief Executive Editor of Frontiers. The authors agree to this retraction.
Citation: Frontiers Editorial Office (2024) Retraction: COL10A1-DDR2 axis promotes the progression of pancreatic cancer by regulating MEK/ERK signal transduction. Front. Oncol. 14:1538142. doi: 10.3389/fonc.2024.1538142
Received: 02 December 2024; Accepted: 02 December 2024;
Published: 10 December 2024.
Approved by:
Liang Qiao, The University of Sydney, AustraliaCopyright © 2024 Frontiers Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Editorial Office, cmVzZWFyY2guaW50ZWdyaXR5QGZyb250aWVyc2luLm9yZw==